tuftsin has been researched along with Aspergillosis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gupta, CM; Haq, W | 1 |
Ahmad, N; Khan, A; Khan, MA; Mannan, A; Moin, S; Owais, M; Pasha, ST; Wajahul, H | 1 |
Faisal, SM; Khan, MA; Mohammad, O | 1 |
Ahmed, I; Bachhawat, BK; Gupta, CM; Jain, RK; Krishnakumar, B; Owais, M | 1 |
4 other study(ies) available for tuftsin and Aspergillosis
Article | Year |
---|---|
Tuftsin-bearing liposomes as antibiotic carriers in treatment of macrophage infections.
Topics: Animals; Anti-Bacterial Agents; Aspergillosis; Drug Carriers; Erythrocytes; Leishmania donovani; Leishmaniasis, Visceral; Liposomes; Macrophages; Mice; Mycobacterium tuberculosis; Neutrophils; Rats; Tuberculosis; Tuftsin | 2005 |
Tuftsin-mediated immunoprophylaxis against an isolate of Aspergillus fumigatus shows less in vivo susceptibility to amphotericin B.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Evaluation, Preclinical; Drug Therapy, Combination; Immunocompromised Host; Immunologic Factors; Liposomes; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Tuftsin | 2005 |
Safety, efficacy and pharmacokinetics of tuftsin-loaded nystatin liposomes in murine model.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Humans; Immunologic Factors; Liposomes; Male; Mice; Microbial Sensitivity Tests; Nystatin; Treatment Outcome; Tuftsin | 2006 |
Tuftsin-bearing liposomes as drug vehicles in the treatment of experimental aspergillosis.
Topics: Amino Acid Sequence; Amphotericin B; Animals; Aspergillosis; Aspergillus fumigatus; Drug Carriers; Humans; Liposomes; Macrophage Activation; Male; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Tuftsin | 1993 |